After losing a prominent physician from the company’s board of directors last week, Organigram Holdings Inc. (TSX V: OGI; OTCQX: OGRMF) is now expanding senior management with three new hires.
In addition to bringing on Tina Shannon as new head of Human Resources to focus on employee expansion, Organigram just recruited Matt Rogers into the role of Plant Manager, where he will oversee the company’s production facilities.
Organigram has also now officially hired strategy consultant James Cavanagh into the newly created Chief of Staff position. Recruited from the multinational services network PwC, Cavanaugh will be tasked with crafting corporate strategy, consulting with company executives, and finding processes to be more efficient.
Chief Executive Officer Greg Engel had this to say about the trio of new hires and the recruitment of a new Chief of Staff:
Organigram has seen a number of upper management shake-ups as the company expands into a major player in the Canadian recreational industry.
Notably, Chief Legal Officer Mike Tripp and head of international operations Guillermo Delmonte both departed the company in recent weeks.
Corporate Secretary Helen Martin was also promoted to the role of SVP of Strategic and Legal Affairs, while longtime company employee Ray Gracewood moved into the position of SVP of Marketing and Communications.
While still providing products for medical patients, the company has seen a shift toward adult use recreational sales since legalization arrived last year, inking a supply deal with British Columbia and completely selling off the Trauma Healing Centers network of clinics to Harvest Medicine Inc.
On the opposite side of the patient / customer spectrum, Organigram just launched a cross-platform mobile app specifically aimed at medial consumers.
By using the app, customers gain a tailored buying experience that includes easily available patient data, former buying habit info, and the ability to directly chat with a representative about the patient’s care plan.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.